909 related articles for article (PubMed ID: 16841345)
1. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
Pasquini M; Biondi M; Costantini A; Cairoli F; Ferrarese G; Picardi A; Sternberg C
Depress Anxiety; 2006; 23(7):441-8. PubMed ID: 16841345
[TBL] [Abstract][Full Text] [Related]
2. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests.
Ozalp E; Soygür H; Cankurtaran E; Turhan L; Akbiyik D; Geyik P
Psychooncology; 2008 Jul; 17(7):668-75. PubMed ID: 17992701
[TBL] [Abstract][Full Text] [Related]
4. Screening for anxiety and depression after stroke: comparison of the hospital anxiety and depression scale and the Montgomery and Asberg depression rating scale.
Sagen U; Vik TG; Moum T; Mørland T; Finset A; Dammen T
J Psychosom Res; 2009 Oct; 67(4):325-32. PubMed ID: 19773025
[TBL] [Abstract][Full Text] [Related]
5. Anxiety disorders in adults treated by hemodialysis: a single-center study.
Cukor D; Coplan J; Brown C; Friedman S; Newville H; Safier M; Spielman LA; Peterson RA; Kimmel PL
Am J Kidney Dis; 2008 Jul; 52(1):128-36. PubMed ID: 18440682
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram in the treatment of anxiety symptoms associated with depression.
Bandelow B; Andersen HF; Dolberg OT
Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
Kim SW; Shin IS; Kim JM; Kim YC; Kim KS; Kim KM; Yang SJ; Yoon JS
Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144
[TBL] [Abstract][Full Text] [Related]
8. Screening for mental disorders in cardiology outpatients.
Birket-Smith M; Rasmussen A
Nord J Psychiatry; 2008; 62(2):147-50. PubMed ID: 18569779
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
Olié JP; Tonnoir B; Ménard F; Galinowski A
Depress Anxiety; 2007; 24(5):318-24. PubMed ID: 17041922
[TBL] [Abstract][Full Text] [Related]
10. The frequency of the psychiatric symptoms in the patients with dyspepsia at a university hospital.
Guz H; Sunter AT; Bektas A; Doganay Z
Gen Hosp Psychiatry; 2008; 30(3):252-6. PubMed ID: 18433657
[TBL] [Abstract][Full Text] [Related]
11. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
Demyttenaere K; Andersen HF; Reines EH
Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
[TBL] [Abstract][Full Text] [Related]
12. Marked depression and anxiety in patients with functional dysphonia.
Willinger U; Völkl-Kernstock S; Aschauer HN
Psychiatry Res; 2005 Mar; 134(1):85-91. PubMed ID: 15808293
[TBL] [Abstract][Full Text] [Related]
13. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
[TBL] [Abstract][Full Text] [Related]
14. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study.
Yoon SJ; Pae CU; Kim DJ; Namkoong K; Lee E; Oh DY; Lee YS; Shin DH; Jeong YC; Kim JH; Choi SB; Hwang IB; Shin YC; Cho SN; Lee HK; Lee CT
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1196-201. PubMed ID: 16624467
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial morbidity and its correlates in cancer patients of the Mediterranean area: findings from the Southern European Psycho-Oncology Study.
Grassi L; Travado L; Moncayo FL; Sabato S; Rossi E;
J Affect Disord; 2004 Dec; 83(2-3):243-8. PubMed ID: 15555721
[TBL] [Abstract][Full Text] [Related]
16. Affective syndromes and their screening in cancer patients with early and stable disease: Italian ICD-10 data and performance of the Distress Thermometer from the Southern European Psycho-Oncology Study (SEPOS).
Grassi L; Sabato S; Rossi E; Marmai L; Biancosino B
J Affect Disord; 2009 Apr; 114(1-3):193-9. PubMed ID: 18757101
[TBL] [Abstract][Full Text] [Related]
17. Trait anxiety and defensive functioning in relation to antidepressant treatment outcome.
Sukul YR; Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA
Psychopathology; 2009; 42(6):387-93. PubMed ID: 19776669
[TBL] [Abstract][Full Text] [Related]
18. Effect of clorazepate on depressed mood in anxious patients.
Zung WW
J Clin Psychiatry; 1987 Jan; 48(1):13-4. PubMed ID: 2879832
[TBL] [Abstract][Full Text] [Related]
19. Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list.
Shim EJ; Shin YW; Jeon HJ; Hahm BJ
Psychooncology; 2008 Jun; 17(6):548-55. PubMed ID: 17957764
[TBL] [Abstract][Full Text] [Related]
20. Validity of the Hospital Anxiety and Depression Scale to assess depression and anxiety following traumatic brain injury as compared with the Structured Clinical Interview for DSM-IV.
Whelan-Goodinson R; Ponsford J; Schönberger M
J Affect Disord; 2009 Apr; 114(1-3):94-102. PubMed ID: 18656266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
